Crushed No More? Whole Tablets Safe in Stroke Dysphagia

A clinical study led by KL Krems finds that whole tablets may be safer than crushed ones for patients with poststroke swallowing disorders — challenging established nursing routines.
By: KL Krems
 
KREMS, Austria - Oct. 28, 2025 - PRLog -- For decades, stroke patients with swallowing difficulties have routinely received crushed tablets to reduce the risk of aspiration. New clinical data now challenge this practice. A study using endoscopic swallowing diagnostics in patients with poststroke dysphagia has shown that whole tablets, when administered with a soft bolus such as applesauce, are often swallowed safely — without signs of penetration or aspiration. In contrast, crushed forms left significantly more residue in the pharynx, potentially impairing drug absorption and increasing the risk of complications. The research, coordinated by the Karl Landsteiner University of Health Sciences (KL Krems), calls into question the default use of crushed tablets and points to the need for updated clinical guidelines. A more differentiated approach could reduce medication errors and improve the safety of pharmaceutical treatment in stroke care.

Poststroke dysphagia is one of the most frequent and serious complications following a stroke, affecting up to 75% of patients. It increases the likelihood of pneumonia, malnutrition, and delays in recovery. While international guidelines recommend standardized screening to detect swallowing impairments, they offer little guidance on how to handle oral medications—especially solid tablets and capsules. In everyday practice, tablets are often crushed or altered without first assessing the patient's ability to swallow. To address this lack of evidence, the Division of Neurology at University Hospital Tulln (a teaching and research centre of KL Krems) coordinated a systematic investigation using fiberoptic endoscopy to evaluate the actual safety of tablet intake.

Scientific Contact

PhDr. Michaela Trapl-Grundschober, MSc

Division of Neurology at University Hospital Tulln

Karl Landsteiner University of Health Sciences

Dr.-Karl-Dorrek-Straße 30

3500 Krems / Austria

T +43 2272/9004-13310

E neurologie@tulln.lknoe.at

Copy Editing & Distribution

PR&D – Public Relations for Research & Education

Dr. Barbara Bauder-Jelitto

Kollersteig 68

3400 Klosterneuburg / Austria

M +43 664 1576 350

E bauder@prd.at

L https://www.linkedin.com/company/prd-public-relations-für-forschung-bildung (https://www.linkedin.com/company/prd-public-relations-f%C...)

W https://www.prd.at/

Contact
PR&D
***@prd.at
End
Source:KL Krems
Email:***@prd.at Email Verified
Tags:Stroke
Industry:Health
Location:Krems - Lower Austria - Austria
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
PR&D - Public Releations for Research & Education News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share